0001213900-25-033930.txt : 20250422 0001213900-25-033930.hdr.sgml : 20250422 20250422080028 ACCESSION NUMBER: 0001213900-25-033930 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250422 DATE AS OF CHANGE: 20250422 EFFECTIVENESS DATE: 20250422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurotrigger Ltd. CENTRAL INDEX KEY: 0001987476 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-544178 FILM NUMBER: 25854992 BUSINESS ADDRESS: STREET 1: 4 SHEZAF STREET CITY: RA'ANANA STATE: L3 ZIP: 4366411 BUSINESS PHONE: 972522963130 MAIL ADDRESS: STREET 1: 4 SHEZAF STREET CITY: RA'ANANA STATE: L3 ZIP: 4366411 D 1 primary_doc.xml X0708 D LIVE 0001987476 Neurotrigger Ltd. 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 +972522963130 ISRAEL None None Corporation true Nikolai Kunicher 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 Executive Officer Chief Executive Officer Michal Marks 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 Executive Officer Director Chief Operating Officer and Director Prof. Eyal Gur 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 Executive Officer Medical Director Dr. Assaf Deutsch 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 Executive Officer Director R&D Director and Director Shachar Paz 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 Director Dr. Hagit Deutsch 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 Director Shalom Auerbach 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 Director James Mazzo 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 Director Dr. Barak Azmon 3 HATAMAR STREET EVEN YEHUDA L3 ISRAEL 4050003 Director Biotechnology Decline to Disclose 06b false 2024-10-31 false true false 0 Ceros Financial Services, Inc. 000037869 None None 1445 RESEARCH BOULEVARD ROCKVILLE MD MARYLAND 20850 GA GEORGIA IL ILLINOIS LA LOUISIANA WI WISCONSIN true 520000 520000 0 true 0 6 52000 0 582 warrants to purchase shares of common stock at an exercise price of $89.45 per share, and reimbursement of up to $75,000 in expenses. 0 false Neurotrigger Ltd. /s/ Nikolai Kunicher Nikolai Kunicher Chief Executive Officer 2025-04-22